Green Hygienics Holdings Inc. (GRYN) Recruits Former Johnson & Johnson Head of Regulatory & Medical Affairs, Italy, as New Chief Scientific Officer

Rhea-AI Summary

Green Hygienics Holdings Inc. (OTCQB: GRYN) has appointed Dr. Francesca Serraino Fiory as the new Chief Scientific Officer. She will lead product development and R&D efforts under the company’s biotech subsidiary, TruLife Biotech, while also forging partnerships with research institutions. Dr. Serraino Fiory has extensive experience in regulatory affairs, having worked at Pfizer and Johnson & Johnson, and has a strong background in both Eastern and Western medicine. The company focuses on cultivating industrial hemp and manufacturing pharmaceutical-grade cannabinoids.

Positive

• Appointment of Dr. Francesca Serraino Fiory as Chief Scientific Officer is a strategic move for enhancing product development.
• Dr. Serraino Fiory's extensive regulatory and industry experience may strengthen partnerships with research centers and accelerate growth.
• Commitment to maintaining high standards in the cultivation of industrial hemp and cannabinoid manufacturing.

Negative

• None.

SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") has appointed Dr. Francesca Serraino Fiory as the Company’s new Chief Scientific Officer. Dr. Serraino Fiory will oversee product development, accelerating the Company’s multibrand portfolio, and manage R&D efforts under the Company’s wholly owned biotechnology subsidiary, TruLife Biotech. She will also lead collaborative partnerships with research centers and academic institutions and drive sustainable growth by guiding the Company across the global regulatory landscape.

After obtaining her master’s degree in Industrial Chemistry from the University of Rome, La Sapienza and a Ph.D. in Material Engineering from the University of Rome, Tor Vergata, Dr. Serraino Fiory began her career in the pharmaceutical industry. Starting in Regulatory and Medical Affairs at Pfizer, she then took on the role of head of Regulatory and Medical Affairs at Johnson & Johnson Consumer Health Care, Italy. Perrigo Pharma then recruited her to serve as Regulatory, Quality and Medical Affairs director. In this role, Dr. Serraino Fiory oversaw the Italian regulatory medical, quality, pharmacovigilance and legal team of Perrigo Pharma Italia. She also led the Italian affiliate’s portfolio, which included medicinal products, cosmetic products, medical devices, food supplements, biocides and veterinary products. During a career that spanned two decades of side-by-side work with European Health Authorities and the FDA, she developed a keen knowledge of the pharmaceutical environment, medicinal products, herbals, medical devices, cosmetics and food supplements.

Dr. Serraino Fiory is also a Certified Nutritional Consultant, Clinical Master Herbalist, Clinical Aromatherapist and Certified Holistic Health Practitioner in Traditional Chinese Medicine. She is currently attending the DACM program at Pacific College of Health and Science in San Diego to become a Doctor in Acupuncture and Chinese Medicine. Her firsthand and inside experience with both Eastern and Western Medicine has led her to cultivate a 360-degree perspective on the best practices for achieving and maintaining optimum health.

About Green Hygienics Holdings Inc.

Green Hygienic Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

Hygienics is the science of preserving and promoting the health of individuals, communities and the planet.

For further information about Green Hygienics Holdings Inc., please visit the Company’s website at: http://www.greenhygienics.com/

Follow us on  Facebook, Twitter, Instagram and Linkedin.

Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll Free 1.855.802.0299

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

This document contains forward-looking statements. In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Public Relations:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

FAQ

Who is the new Chief Scientific Officer of Green Hygienics Holdings Inc. (GRYN)?

Dr. Francesca Serraino Fiory has been appointed as the new Chief Scientific Officer of Green Hygienics Holdings Inc. (GRYN).

What are Dr. Francesca Serraino Fiory's qualifications?

Dr. Francesca Serraino Fiory holds a master's degree in Industrial Chemistry and a Ph.D. in Material Engineering, with extensive experience in regulatory affairs in the pharmaceutical industry.

What is the focus of Green Hygienics Holdings Inc. (GRYN)?

Green Hygienics Holdings Inc. (GRYN) is focused on the cultivation of industrial hemp and the manufacturing of pharmaceutical-grade bioactive cannabinoids.

What role will Dr. Serraino Fiory play at Green Hygienics Holdings Inc. (GRYN)?

Dr. Serraino Fiory will oversee product development, manage R&D efforts, and lead collaborative partnerships with research centers.